AG102

N/A

Report date: 2023/06/16 17:55:14
NME

Base Information

Drug NameAG102
Drug Alias NameAG102AG-102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAngiogenesis inhibitorsEpidermal growth factor inhibitorsLaminin receptors antagonists
TargetsEpidermal growth factorLaminin receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrogene Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrogene Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A